Eisai Co (TSE:4523) Forward PE Ratio : 0.00 (As of Apr. 28, 2024)

View and export this data going back to 1961. Start your Free Trial

What is Eisai Co Forward PE Ratio?

Eisai Co's Forward PE Ratio for today is 0.00.

Eisai Co's PE Ratio without NRI for today is 37.06.

Eisai Co's PE Ratio for today is 37.06.

Eisai Co Forward PE Ratio Historical Data

The historical data trend for Eisai Co's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eisai Co Forward PE Ratio Chart

Eisai Co Annual Data

Trend

2018-12

2019-12

2020-12

2021-12

2022-12

2023-12

2024-01

Forward PE Ratio

35.21

27.70

21.37

26.32

38.31

34.36

36.50

Eisai Co Quarterly Data
	2018-03	2018-06	2018-09	2018-12	2019-03	2019-06	2019-09	2019-12	2020-03	2020-06	2020-09	2020-12	2021-03	2021-06	2021-09	2021-12	2022-03	2022-06	2022-09	2022-12	2023-03	2023-06	2023-09	2023-12
Forward PE Ratio	34.01	36.63	51.81	35.21	25.77	24.57	19.69	27.70	24.33	28.25	30.77	21.37	26.74	72.99	53.48	26.32	23.92	33.90	47.17	38.31	33.11	78.74	67.11	34.36

Competitive Comparison of Eisai Co's Forward PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Eisai Co's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Eisai Co's Forward PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eisai Co's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Eisai Co's Forward PE Ratio falls into.

Eisai Co Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.

Eisai Co (TSE:4523) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .

Eisai Co Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Eisai Co's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Eisai Co (TSE:4523) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eisai Co Ltd (TSE:4523) » Definitions » Forward PE Ratio

Comparable Companies

Traded in Other Exchanges

ESAIY:USA ESALF:USA EII:Germany

Address

4-6-10 Koishikawa, Bunkyo-ku, Tokyo, JPN, 112-8088

Website

http://www.eisai.co.jp

Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of a pharmaceutical business and other businesses. The pharmaceutical business is categorized by region, including Japan, Americas, China, Asia, and Europe, Middle East, and Africa. Eisai also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived by its Japanese pharmaceutical business, followed by its Americas pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.

Eisai Co (TSE:4523) Headlines

No Headlines